Carbamazepine 100 mg/1 (Carbamazepine TABLET, CHEWABLE) 100 mg/1

Carbamazepine 100 mg chewable tablets are an anticonvulsant medication used to manage certain types of seizures and nerve pain. This oral medication is designed for easy administration and absorption.

Strength

100 mg/1

Pack Size

30 TABLET, CHEWABLE in 1 BLISTER PACK (0615-8125-39)

Manufacturer / TM Owner

NCS HealthCare of KY, LLC dba Vangard Labs

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carbamazepine is primarily used to control seizures and treat nerve pain, such as trigeminal neuralgia. It works by stabilizing electrical activity in the brain and affecting how nerves send pain signals. This medication is often prescribed for conditions where other treatments have not been effective.

Side Effects

Common effects of Carbamazepine may include dizziness, drowsiness, and nausea. Some users might experience blurred vision or coordination problems. These effects can vary and may improve as the body adjusts to the medication.

Precautions & Warnings

Carbamazepine should be handled with care, especially for individuals with a history of liver or kidney disease. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Avoid activities that require alertness until you know how this medication affects you.

Avoid Interactions

Carbamazepine may interact with other medications, including certain antidepressants, antibiotics, and antifungal drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other central nervous system depressants should be used with caution.

Frequently Asked Questions

Carbamazepine is used to control seizures and treat nerve pain, such as trigeminal neuralgia.

Chewable tablets should be chewed thoroughly before swallowing. Follow the dosage instructions provided by your healthcare provider.

Common side effects include dizziness, drowsiness, nausea, blurred vision, and coordination problems.

Carbamazepine may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Carbamazepine should be used with caution in individuals with liver or kidney disease. Always consult a healthcare provider before starting this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.